Bank of Nova Scotia Sells Majority of Apellis Pharmaceuticals Shares / is on Nostr

Bank of Nova Scotia sells majority of Apellis Pharmaceuticals shares

Last Notes

2024-07-01 13:50:50

Bank of Nova Scotia Sells Majority of Apellis Pharmaceuticals Shares, Novo Nordisk Initiates Share Repurchase Program
===============
#decb3279 ver:0.07
Bank of Nova Scotia sells majority of Apellis Pharmaceuticals shares, reducing its position by 97.8%. Novo Nordisk initiates share repurchase program, planning to repurchase B shares for up to DKK 20 billion. #Pharmaceuticals #Investing...
#newstr #BankOfNovaScotia #ApellisPharmaceuticals #NovoNordisk #ShareRepurchase #Biopharmaceuticals
https://here.news/story/decb3279?ver=0.07

2024-06-09 10:06:27

Bank of Nova Scotia Sells Majority of Apellis Pharmaceuticals Shares
===============
#decb3279 ver:0.06
Bank of Nova Scotia sells majority of Apellis Pharmaceuticals shares, reducing its position by 97.8%. Other hedge funds also making changes. Insiders actively selling stock. Analysts rate APLS as 'Moderate Buy' with target price of $74.38. Apellis Pharmaceuticals focuses on autoimmune and inflammatory diseases. Market cap of $4.90 billion. Investors should conduct thorough research. #biopharma #investing...
#newstr #ApellisPharmaceuticals #Nasdaq:apls #BankOfNovaScotia #HedgeFunds #AnalystRatings #InsiderTrades #BiopharmaceuticalCompany #TherapeuticCompounds #AutoimmuneDiseases #InflammatoryDiseases #Empaveli #Syfovre #MarketCap #EarningsPerShare #Revenue
https://here.news/story/decb3279?ver=0.06